All In MedTech

Device Trial Radar · NCT07468370

Real Time Craniotomy Planning Using Mixed Reality

Investigation of Augmented Reality/Mixed Reality Viewer for Surgical Planning in Cranial Surgery

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

54

Planned (sponsor's estimate)

Start

Oct 2026

Primary completion

Jun 2027

Study completion Jun 2027

Sponsor

Lead sponsor
Brainlab AGNot on our public-company list
Sponsor type
Industry
First posted
Mar 12, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

This study is a prospective observational study designed to evaluate the effectiveness of Brainlab's Mixed Reality Viewer in enhancing the accuracy and efficiency of preoperative craniotomy planning. The study will be conducted at a single site with two enrollment groups. Group 1 has a target enrollment of 38 subjects. Group 2 has a target enrollment of 16 subjects. By observing the device's use during standard surgical procedures, we can accurately measure its impact on incision planning accuracy, time efficiency, and overall ease of use compared to traditional neuronavigation systems. This design allows for the collection of both quantitative and qualitative data, providing a robust assessment of the Mixed Reality Viewer's potential to enhance surgical outcome

Conditions

  • Neurosurgery
  • Surgical Planning
  • Brain Tumor Adult
  • Craniotomy Tumor Removal Surgery

Interventions

  • Mixed Reality Glasses/ViewerDevice

    Mixed reality glasses with 3D viewer used to visualize cranitomy planning environment for incision planning and patient positioning

  • Survey using a questionnaire.Other

    A survey will be completed by hospital personnel that use the mixed reality environment (glasse and viewer) to evaluate craniotomy planning for participants in the Brain Tumor Group

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quantitative Assessment of Incision Planning AccuracyTime frame: During the craniotomy incision planning stage that starts when Neurosurgeon begins planning incision on pre-operative cranial planning software (typically the day before surgery) and ends when the incision has been planned in the OR before draping

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Brigham and Women's Hospital, Inc.

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.